If you’re on LinkedIn, take a look at Raybow Info, Raybow USA’s LinkedIn newsletter.

The February edition features Raybow USA’s role in two published studies.

A Raybow USA co-authored article, “Industrial-scale chemical synthesis of gold nanorods: process optimization and 30 L scale-up toward GMP manufacturing,” was recently published in the Journal of Industrial and Engineering Chemistry.

Raybow USA supported the synthetic process for Sophrosyne Pharmaceuticals’ Preclinical Research on Alcohol Use Disorder Therapy preclinical data for SOPH-110S, as published in the peer reviewed journal, Cells. The article is entitled “A Novel ALDH2 Inhibitor for the Treatment of Alcohol Use Disorder: Preclinical Findings.”

To request a meeting, message us directly on LinkedIn — Matthew Lauer, Sherida Johnson, PhD, Tim Miley, David Perrey, Nathaniel Kim, Yuening “Nathan” Jiao, or Gary Richoux.

Molecule to Market; Your Trusted Partner.

Of course, you can also use a ‘Contact Us’ form on this website to reach out!

#syntheticchemistry #analyticalchemistry #pharmaceuticals #cdmo #pharmaceuticalresearchanddevelopment #methoddevelopment #gmp #smallmolecule #TIDES